Singapore
Intellect engages with MSIG Hong Kong to provide holistic mental health support to their policyholders
The market-leading insurance company saw the need for a personalised and comprehensive platform that would address the issue ...
July 05, 2022 | Opinion
Mesh Bio and MultiOmic Health partner to advance precision medicines and diagnostics for chronic metabolic disease in Asia with AI
Mesh will collaborate with its network of healthcare provider customers to recruit patients for the study. MultiOmic will generate genomic, proteomic, meta...
June 30, 2022 | News
GSK's Zejula (niraparib) Tablet approved in Singapore for first-line and recurrent monotherapy maintenance treatment in advanced ovarian cancer
GlaxoSmithKline (GSK) Singapore today announced that Health Sciences Authority has approved Zejula (niraparib) Tablet, an oral, on...
June 29, 2022 | News
Johnson & Johnson Opens First Satellite Center for Global Health Discovery in Asia Pacific at Duke-NUS to Advance Dengue Research
This effort will build on Johnson & Johnson's decade-long legacy and ongoing collaboration with Duke-NUS in early-stage dengue research The Satellite ...
June 21, 2022 | News
Novotech and Medidata expand partnership to continue advancements in clinical research
Medidata, a Dassault Systèmes company, today announced its renewed, expanded partnership with Novotech, a leading contract research organisation (CR...
June 16, 2022 | News
DIA and CoRE Gathering Key Healthcare Experts in Neutral Forum to Discuss Regulatory News and Drug Development
The COVID-19 pandemic has ushered an increased speed of healthcare innovations with the hope of effectively managing this public health threat. This meetin...
June 16, 2022 | News
New Data Highlights People Living With HIV Who Are Virally Suppressed Experience Similar Health-related Quality of Life as General Population
Gilead Sciences, Inc. today announced results from an online survey that assessed the health-related quality of life (HRQOL) among people living with HIV (...
June 16, 2022 | News
NeuroAiD has shown favourable outcome in patients suffering from spinal cord injuries
NeuroAiD was safe as add-on treatment in patients with severe SCI. One third of patients improved on ASIA Impairment Scale (AIS) grading with ...
June 07, 2022 | News
Made-In-Singapore Cancer Drug ETC-159 Advances In Clinical Trials
A made-in-Singapore cancer drug, ETC-159, has advanced into the dose expansion portion of its Phase 1B clinical trial. The Phase 1B dose expansion st...
June 06, 2022 | News
Boehringer Ingelheim Enters Global Licensing Agreement to Develop and Commercialize Innovative Antibodies from A*STAR for Targeted Cancer Therapies
- Boehringer Ingelheim gains exclusive global rights to a panel of cancer-specific antibodies to enable the development of targeted cancer therapies- These...
June 03, 2022 | News
World's first contactless blood pressure and vital sign measurement comes to Singapore
NuraLogix are the pioneers of the world's first contactless blood pressure and vital sign measurement. Their technology uses their patented Transdermal Op...
June 01, 2022 | News
Birmingham Biotech and Tanner Pharma Group enter distribution partnership for innovative nasal spray in Latin America
TannerLAC provides pharmaceutical, biotech, and healthcare companies with a single-point partner for the commercialization of their products in challenging...
June 01, 2022 | News
GenScript Biotech Collaborates with Singapore Institute of Technology on Talent Development and Applied Research Projects
Under the agreement, GenScript will provide internship, full-time employment, industry networking and field service project opportunities for SIT students ...
May 26, 2022 | News
New therapeutic option to reduce risk of cardiovascular deaths and repeated hospitalizations among adult heart failure patients approved in Singapore
Over the course of the VICTORIA study, there was a 4.2% reduction in annualized absolute risk with VERQUVO™ (vericiguat) compared with pl...
May 18, 2022 | News
Most Read
- Lack of Regular Screening Fuels Rise in Late-Stage Breast Cancer in Hong Kong, New Report Reveals
- BIOCHINA 2025: Connecting Global Innovators with China's Leading Biotech Firms
- Leon Wyszkowski, President of Analytical Services, Discusses Thermo Fisher's Strategic Move: Expanding Bioanalytical Capabilities in Europe with New Sweden Lab
- The Role of Policy and Public Health Initiatives in Addressing Women's Cancer Care in Asia
- Redefining Patient Safety in the Age of Healthtech
Bio Jobs
- Avance Clinical Appoints Jessica Han as Director of Asian Operations, Strengthening Commitment to the Asian Market
- Bristol Myers Squibb Employees Cycle Coast-to-Coast to Raise $1 Million for Cancer Research
- Pfizer Australia Commits $150M to Upgrade Melbourne Facility, Bolstering Global Fight Against Antimicrobial Resistance
- SMi Systems Appoints Dr. Stefan Hamill as Vice President of Strategy to Drive Commercialisation and Growth
- Thermo Fisher Scientific Appoints William Hung as Senior Director and General Manager for Taiwan
- Cytiva Appoints Industry Veteran Pierre-Alain Ruffieux as Chief Operating Officer
News
Editor Picks
